Maravai LifeSciences Holdings, Inc.

BMV:MRVI * Stock Report

Market Cap: Mex$36.0b

Maravai LifeSciences Holdings Past Earnings Performance

Past criteria checks 0/6

Maravai LifeSciences Holdings has been growing earnings at an average annual rate of 10%, while the Life Sciences industry saw earnings growing at 24.7% annually. Revenues have been growing at an average rate of 17.6% per year.

Key information

10.0%

Earnings growth rate

-15.9%

EPS growth rate

Life Sciences Industry Growth12.9%
Revenue growth rate17.6%
Return on equity-15.5%
Net Margin-41.2%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Maravai LifeSciences Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BMV:MRVI * Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23289-11915117
30 Sep 234202515021
30 Jun 235447514021
31 Mar 2371815313419
31 Dec 2288322012918
30 Sep 2290723811516
30 Jun 2292024810915
31 Mar 2289522610515
31 Dec 217991829815
30 Sep 216691501168
30 Jun 215521271088
31 Mar 21381781015
31 Dec 2028477946
31 Dec 19143-8484
31 Dec 18124-18414

Quality Earnings: MRVI * is currently unprofitable.

Growing Profit Margin: MRVI * is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MRVI * is unprofitable, but has reduced losses over the past 5 years at a rate of 10% per year.

Accelerating Growth: Unable to compare MRVI *'s earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MRVI * is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-5.1%).


Return on Equity

High ROE: MRVI * has a negative Return on Equity (-15.51%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.